Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: To explore the risk factors associated with falls in elderly lung cancer patients with sarcopenia, construct a predictive model, and validate its performance.

Methods: This cross-sectional study involved 316 lung cancer patients with sarcopenia who were hospitalized in the oncology, thoracic surgery, and respiratory medicine departments of a tertiary hospital in Jiangxi Province between January 2023 and December 2023. Data were collected through questionnaires and physical measurements. A logistic regression predictive model was developed on the basis of independent risk factors.

Results: The incidence of falls among elderly lung cancer patients with sarcopenia was 19.94%. Multivariate logistic regression analysis identified multiple metastases, nocturia (≥3 times per night), sleep disorders, frailty, and malnutrition as independent risk factors for falls. The Hosmer - Lemeshow test indicated good model fit (X = 5.353, =0.719), with an overall predictive accuracy of 83.7%. The area under the ROC curve (AUC) was 0.832, and the Youden index reached a maximum of 0.577, corresponding to a sensitivity of 74.7%, specificity of 83.0%, and an optimal cut-off value of 0.221.

Conclusion: The risk prediction model for falls in elderly lung cancer patients with sarcopenia, which is based on independent predictors, demonstrated good predictive performance. This model facilitates the timely identification of high-risk patients, providing scientific evidence to support the development of precise clinical management strategies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12226475PMC
http://dx.doi.org/10.3389/fonc.2025.1533368DOI Listing

Publication Analysis

Top Keywords

lung cancer
20
cancer patients
20
patients sarcopenia
20
falls elderly
16
elderly lung
16
risk prediction
8
prediction model
8
model falls
8
risk factors
8
predictive model
8

Similar Publications

Segmentectomies Made Easy series: robotic-assisted right S1 and S2 segmentectomy.

Multimed Man Cardiothorac Surg

September 2025

Department of Thoracic Surgery, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK

Three-dimensional (3D) guided robotic-assisted thoracic surgery is increasingly recognized as the pioneering approach for the most complex of pulmonary resections, offering high-definition 3D visualization, enhanced instrument augmentation and tremor-free tissue articulation. Compared with open thoracotomy, the robotic platform is associated with reduced peri-operative morbidity, shorter hospital admissions and faster patient recovery. However, sublobar resections such as segmentectomies remain anatomically and technically demanding, particularly in the context of resecting multiple segments, as showcased in this right S1 and S2 segmentectomy.

View Article and Find Full Text PDF

Segmentectomies Made Easy series: robotic-assisted left S1 and S2 segmentectomy.

Multimed Man Cardiothorac Surg

September 2025

Department of Cardiothoracic Surgery, St George’s Hospital, St George's University Hospitals NHS Foundation Trust, London, UK

Three-dimensional (3D) guided robotic-assisted thoracic surgery is increasingly recognized as a leading technique for undertaking the most complex pulmonary resections, providing high-definition 3D visualization, advanced instrument control and tremor-free tissue handling. Compared with open thoracotomy, the robotic platform offers reduced peri-operative complications, shorter hospital stays and faster patient recovery. Nevertheless, sublobar resections, such as segmentectomies, remain both anatomically intricate and technically challenging, particularly when resecting multiple segments, as in this left S1 and S2 segmentectomy.

View Article and Find Full Text PDF

Despite significant advancements in the treatment of non-small cell lung cancer (NSCLC) using conventional therapeutic methods, drug resistance remains a major factor contributing to disease recurrence. In this study, we aimed to explore the potential benefits of combining PI3K inhibition with Cisplatin in the context of NSCLC-derived A549 cells. Human non-small cell lung cancer A549 cells were cultured and treated with BKM120, cisplatin, or their combination.

View Article and Find Full Text PDF

Metastatic involvement (MB) of the breast from extramammary malignancies is rare, with an incidence of 0.09-1.3% of all breast malignancies.

View Article and Find Full Text PDF

Purpose: To develop and validate an integrated model based on MR high-resolution vessel wall imaging (HR-VWI) radiomics and clinical features to preoperatively assess periprocedural complications (PC) risk in patients with intracranial atherosclerotic disease (ICAD) undergoing percutaneous transluminal angioplasty and stenting (PTAS).

Methods: This multicenter retrospective study enrolled 601 PTAS patients (PC+, n = 84; PC -, n = 517) from three centers. Patients were divided into training (n = 336), validation (n = 144), and test (n = 121) cohorts.

View Article and Find Full Text PDF